A schematic of the influenza virus surface where the blue tetramers are the neuraminidase glycoprotein and the brown trimers are the hemagglutinin glycoprotein.
A ribbon model of the structure of influenza neuraminidase glycoprotein. The Wilson and Krammer laboratories found that maintaining the structure of neuraminidase during the production of future influenza vaccines could substantially improve protection from influenza infection.
Patrick Wilson, who led the UChicago Medicine team, and study co-author Nai-Ying Zheng in a laboratory in the Knapp Center for Lupus and Immunology Research at the University of Chicago